BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 16036530)

  • 21. Faecal elastase-I: helpful in analysing steatorrhoea?
    Symersky T; van der Zon A; Biemond I; Masclee AA
    Neth J Med; 2004 Sep; 62(8):286-9. PubMed ID: 15588069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pancreatic exocrine insufficiency in HIV-positive patients.
    Price DA; Schmid ML; Ong EL; Adjukeiwicz KM; Peaston B; Snow MH
    HIV Med; 2005 Jan; 6(1):33-6. PubMed ID: 15670250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does secretin-stimulated MRCP predict exocrine pancreatic insufficiency?: A comparison with noninvasive exocrine pancreatic function tests.
    Schneider AR; Hammerstingl R; Heller M; Povse N; Murzynski L; Vogl TJ; Caspary WF; Stein J
    J Clin Gastroenterol; 2006 Oct; 40(9):851-5. PubMed ID: 17016144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of faecal lipase test and faecal elastase-1 test in the assessment of exocrine pancreatic function in cystic fibrosis].
    Walkowiak J; Herzig KH; Strzykala K; Lisowska A; Przyslawski J; Grzymislawski M; Krawczynski M
    Med Wieku Rozwoj; 2003; 7(2):149-55. PubMed ID: 12878785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Undiagnosed pancreatic exocrine insufficiency and chronic pancreatitis in functional GI disorder patients with diarrhea or abdominal pain.
    Talley NJ; Holtmann G; Nguyen QN; Gibson P; Bampton P; Veysey M; Wong J; Philcox S; Koloski N; Bunby L; Jones M
    J Gastroenterol Hepatol; 2017 Nov; 32(11):1813-1817. PubMed ID: 28332731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low fecal elastase: potentially related to transient small bowel damage resulting from enteric pathogens.
    Salvatore S; Finazzi S; Barassi A; Verzelletti M; Tosi A; Melzi d'Eril GV; Nespoli L
    J Pediatr Gastroenterol Nutr; 2003 Mar; 36(3):392-6. PubMed ID: 12604981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low prevalence of exocrine pancreatic insufficiency in patients with diabetes mellitus.
    Vujasinovic M; Zaletel J; Tepes B; Popic B; Makuc J; Epsek Lenart M; Predikaka M; Rudolf S
    Pancreatology; 2013; 13(4):343-6. PubMed ID: 23890131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of faecal elastase-1 assay in monitoring pancreatic function in childhood coeliac disease.
    Carroccio A; Iacono G; Ippolito S; Verghi F; Cavataio F; Soresi M; Giannitrapani L; Notarbartolo A; Montalto G
    Ital J Gastroenterol Hepatol; 1998 Oct; 30(5):500-4. PubMed ID: 9836106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fecal pancreatic elastase: a reproducible marker for severe exocrine pancreatic insufficiency.
    Naruse S; Ishiguro H; Ko SB; Yoshikawa T; Yamamoto T; Yamamoto A; Futakuchi S; Goto H; Saito Y; Takahashi S
    J Gastroenterol; 2006 Sep; 41(9):901-8. PubMed ID: 17048055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fecal pancreatic elastase in infants under 2 years of age.
    Benahmed NA; Manene D; Barbot L; Kapel N
    Ann Biol Clin (Paris); 2008; 66(5):549-52. PubMed ID: 18957344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Should we Investigate Gastroenterology Patients for Pancreatic Exocrine Insufficiency? A Dual Centre UK Study.
    Campbell JA; Sanders DS; Francis KA; Kurien M; Lee S; Taha H; Ramadas A; Joy D; Hopper AD
    J Gastrointestin Liver Dis; 2016 Sep; 25(3):303-9. PubMed ID: 27689193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a fecal pancreatic elastase-1 enzyme-linked immunosorbent assay: Assessment versus an established assay and implication in classifying pancreatic function.
    Erickson JA; Aldeen WE; Grenache DG; Ashwood ER
    Clin Chim Acta; 2008 Nov; 397(1-2):87-91. PubMed ID: 18706899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exocrine pancreatic insufficiency and chronic pancreatitis in chronic alcoholic liver disease: coincidence or shared toxicity?
    Aoufi Rabih S; García Agudo R; Legaz Huidobro ML; Ynfante Ferrús M; González Carro P; Pérez Roldán F; Ruiz Carrillo F; Tenías Burillo JM
    Pancreas; 2014 Jul; 43(5):730-4. PubMed ID: 24713840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How useful is fecal pancreatic elastase 1 as a marker of exocrine pancreatic disease?
    Beharry S; Ellis L; Corey M; Marcon M; Durie P
    J Pediatr; 2002 Jul; 141(1):84-90. PubMed ID: 12091856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pancreatic exocrine dysfunction in maturity-onset diabetes of the young type 3.
    Vesterhus M; Raeder H; Johansson S; Molven A; Njølstad PR
    Diabetes Care; 2008 Feb; 31(2):306-10. PubMed ID: 17989309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exocrine pancreatic function in patients with end-stage renal disease.
    Griesche-Philippi J; Otto J; Schwörer H; Maisonneuve P; Lankisch PG
    Clin Nephrol; 2010 Dec; 74(6):457-64. PubMed ID: 21084049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic exocrine function and morphology following an episode of acute pancreatitis.
    Xu Y; Wu D; Zeng Y; Wang X
    Pancreas; 2012 Aug; 41(6):922-7. PubMed ID: 22481293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic Elastase Levels in Feces As A Marker of Exocrine Pancreatic Function in Patients With Diabetes Mellitus.
    Kangrga RN; Ignjatović SD; Dragašević MM; Jovičić SŽ; Majkić-Singh NT
    Lab Med; 2016 May; 47(2):140-8. PubMed ID: 27069032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low fecal elastase 1 levels do not indicate exocrine pancreatic insufficiency in type-1 diabetes mellitus.
    Hahn JU; Kerner W; Maisonneuve P; Lowenfels AB; Lankisch PG
    Pancreas; 2008 Apr; 36(3):274-8. PubMed ID: 18362841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fecal elastase-1 as a test for pancreatic function: a review.
    Dominici R; Franzini C
    Clin Chem Lab Med; 2002 Apr; 40(4):325-32. PubMed ID: 12059069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.